Research

Search dozens of publications about studies conducted with real-world data, powered by Datavant technology as well as the COVID-19 Research Database.

Filter By

Amivantamab compared with real-world therapies in patients with NSCLC with EGFR Exon 20 insertion mutations who have progressed after platinum doublet chemotherapy

Amivantamab is an epidermal growth factor receptor (EGFR)-MET bispecific antibody with immune cell-directing activity.

LEARN MORE
Variability in comorbidities and health services use across homeless typologies: multicenter data linkage between healthcare and homeless systems
LEARN MORE
Racial Disparities in Ischemic Stroke Among Patients with COVID-19 in the United States

Alain Lekoubou MD, MSc; Matt Pelton, BA; Djibril M., Ba MPH; Paddy Ssentongo MD, PhD, MPH

LEARN MORE
Trends in filled naloxone prescriptions before and during the COVID-19 Pandemic in the United States

Ashley L. O’Donoghue, PhD; Nayantara Biswas, MA; Tenzin Dechen, MPH, et al

LEARN MORE
Relative Effectiveness of the Cell-derived Inactivated Quadrivalent Influenza Vaccine Versus Egg-derived Inactivated Quadrivalent Influenza Vaccines in Preventing Influenza-related Medical Encounters During the 2018–2019 Influenza Season in the United States

Constantina Boikos, Lauren Fischer, Dan O’Brien, Joe Vasey, Gregg C Sylvester, James A Mansi
This study estimated the relative vaccine effectiveness (rVE) of ccIIV4 versus egg-derived inactivated quadrivalent influenza vaccine (eIIV4) in preventing influenza-related medical encounters in the 2018–2019 US season.

LEARN MORE
Patient access to chronic medications during the COVID-19 pandemic: Evidence from a comprehensive dataset of US insurance claims

Jeffrey Clement, Maura Jacobi, Brad N. Greenwood

LEARN MORE
Primary Care in the COVID-19 Pandemic: Chronic Care Management During the COVID-19 Pandemic

Aaron Baum

LEARN MORE
Intra-household Transmission of Infectious Disease and Gender Inequality

Xinming Du
The study examined how intrahousehold transmission of COVID-19 is impacted by gender inequities.

LEARN MORE
Charges of COVID-19 Diagnostic Testing and Antibody Testing Across Facility Types and States

Mark K. Meiselbach, Ge Bai, Gerard F. Anderson
Research found that a small proportion of COVID-19 diagnostic testing and antibody testing services, provided in selected states, had charges that far exceeded the Medicare rate. High charges may create financial barriers for some uninsured patients and lead to higher premiums for out-of-network private plans.

LEARN MORE